Applying Recent Advances in PET to Clinical Practice Online Course
This course focuses on recent developments in PET agents and technologies that are changing the practice of nuclear medicine and diagnostic imaging. Key indications, common scenarios and practical application in clinical practice will be emphasized. In-Training Members will receive a discounted price of $149 after login
Target Audience:
The target audience for this activity is practicing radiologists and advanced trainees who want additional training on the use of PET tracers and techniques that have recently entered clinical practice.
Goals and Objectives:
After completing the material in this activity, the learner should be able to:
- Discuss the role of PET in prostate cancer and neuroendocrine tumor diagnosis and therapy
- Apply the appropriate PET response criteria in to oncologic studies
- Explain the use of PET agents for the assessment of suspected Alzheimer’s disease and other cognitive disorders
- Outline best practices and imaging findings in PET/CT relevant to COVID-19
- Predict the potential clinical applications of FDOPA-PET for cancer and brain imaging
Disclosure of Commercial Interest:
ARRS staff involved with this activity have nothing to disclose. Below is a listing of activity's contributors and planners’ disclosures:
Planners
Planners
- Eric Rohren has nothing to disclose.
- Jonathan McConathy receives research support from Eli Lilly/Avidd and Blue Earth Diagnostics. Dr. McConathy receives consulting fees from GE Healthcare. He receives research support from Canon Medical and Cytosite Biopharma.
- Kerry Husk has nothing to disclose.
- John Leyendecker has nothing to disclose.
- Jeremiah Long has nothing to disclose.
- Christopher Neumann has nothing to disclose.
- Ali Gholamrezanezhad has nothing to disclose.
- Courtney Moreno has nothing to disclose.
- Eric Rohren has nothing to disclose.
- Geoffrey Johnson has nothing to disclose.
- Ajit Goenka has nothing to disclose.
- Samuel Galgano receives research support as a Primary Investigator for Blue Earth.
- Heather Jacene receives consulting fees as part of the Consulting-Advisory Board for Advanced Accelerator Applications. Dr. Jacene receives a speaker honorarium from Australian and New Zealand Urogenital and Prostate Cancer clinical trial group and Janssen Pharmaceuticals. She receives research support from Siemens Healthcare and GTx, Inc.
- Phillip Kuo receives consulting fees and speaker honoraria as consultant and speaker for General Electric Healthcare. Dr. Kuo receives consulting fee from Imaging Endpoints, Bayer and Novartis. He also receives consulting and reader fees as consultant and reader for clinical trials for Konica Minolta. Dr. Kuo receives a research grant as principal investigator for Blue Earth Diagnostics.
- Jonathan McConathy receives research support from Eli Lilly/Avidd and Blue Earth Diagnostics. Dr. McConathy receives consulting fees from GE Healthcare. He receives research support from Canon Medical and Cytosite Biopharma.
Member Price:
$295.00
NonMember Price:
$545.00
Accreditation Statement
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Designation Statement
The ARRS designates this educational activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.
Date of issuance: October 26, 2020
Date of expiration: October 25, 2023
Estimated time to complete the activity: 4 hour(s)
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
Designation Statement
The ARRS designates this educational activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s)™.
The American Roentgen Ray Society (ARRS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The ARRS designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credit(s)™ and 4 American Board of Radiology©, MOC Part II, Self-Assessment CME (SA-CME.) Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of issuance: October 26, 2020
Date of expiration: October 25, 2023
Estimated time to complete the activity: 4 hour(s)